Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,136,484 papers from all fields of science
Search
Sign In
Create Free Account
DACA, acridine
Known as:
Acridine Carboxamide
, DACA
, N-(2-(Dimehtylamino)ethyl)acridine-4-carboxamide
A tricyclic acridine-based (or carboxamide-based) drug with dual topoisomerase inhibitor and potential antineoplastic activities. Acridine…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Broader (1)
Acridines
NCIt Antineoplastic Agent Terminology
Narrower (2)
NSC 601316
XR 5000
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Undocumented Students Pursuing Medical Education: The Implications of Deferred Action for Childhood Arrivals (DACA)
Yohualli Balderas-Medina Anaya
,
Mithi del Rosario
,
L. H. Doyle
,
D. Hayes-Bautista
Academic medicine : journal of the Association of…
2014
Corpus ID: 203756519
There are about 1.8 million young immigrants in the United States who came or were brought to the country without documentation…
Expand
2013
2013
Evaluation of Rhesus Monkey and Guinea Pig Hepatic Cytosol Fractions as Models for Human Aldehyde Oxidase
Kanika V. Choughule
,
J. T. Barr
,
Jeffrey P. Jones
Drug Metabolism And Disposition
2013
Corpus ID: 9339713
Aldehyde oxidase (AOX) is a cytosolic enzyme expressed across a wide range of species, including guinea pig and rhesus monkey…
Expand
2004
2004
Experimental solid tumour activity ofN-[2-(dimethylamino)ethyl]-acridine-4-carboxamide
B. Baguley
,
Zhuang Li
,
E. Marshall
Cancer Chemotherapy and Pharmacology
2004
Corpus ID: 33026293
N-[2-(Dimethylamino)ethyl]acridine-4-carboxamide (DACA), a DNA intercalator that exerts its antitumour action through the enzyme…
Expand
Review
2003
Review
2003
Phase II study of XR 5000 (DACA), an inhibitor of topoisomerase I and II, administered as a 120-h infusion in patients with non-small cell lung cancer.
C. Dittrich
,
B. Coudert
,
+7 authors
P. Fumoleau
European Journal of Cancer
2003
Corpus ID: 23669450
Highly Cited
2002
Highly Cited
2002
Anticancer, antiradical and antioxidative actions of novel Antoksyd S and its major components, baicalin and baicalein.
E. Ciesielska
,
Antoni Gwardys
,
D. Metodiewa
Anticancer Research
2002
Corpus ID: 12165369
Here we show for the first time that the novel designed drug, Antoksyd S and its polyphenolic flavones (baicalin and baicalein…
Expand
Highly Cited
1998
Highly Cited
1998
Pharmacokinetic assessment of novel anti-cancer drugs using spectral analysis and positron emission tomography: A feasibility study
S. Meikle
,
J. Matthews
,
+5 authors
P. Price
Cancer Chemotherapy and Pharmacology
1998
Corpus ID: 29401230
Purpose: The aim of this study was to investigate the feasibility of evaluating the pharmacokinetics of radiolabeled anti-cancer…
Expand
1998
1998
Distal anterior cerebral artery aneurysms: a clinical series.
P. Ng
,
P. Reilly
,
B. Brophy
,
S. Halcrow
British Journal of Neurosurgery
1998
Corpus ID: 33761287
Thirty patients with distal anterior cerebral artery (DACA) aneurysms were seen at the Royal Adelaide Hospital in the period 1970…
Expand
1993
1993
Amino acid substitutions at position 47 of human beta 1 beta 1 and beta 2 beta 2 alcohol dehydrogenases affect hydride transfer and coenzyme dissociation rate constants.
C. Stone
,
W. F. Bosron
,
M. Dunn
Journal of Biological Chemistry
1993
Corpus ID: 21917604
1993
1993
Learning and Recognition of 3-D Objects from Brightness Images *
H. Murase
,
S. Nayar
1993
Corpus ID: 14373582
We address the problem of automatically learning object models for recognition and pose estimation. In contrast to the…
Expand
1979
1979
A simple assay for measurement of urinary p-aminobenzoic acid in the oral pancreatic function test.
Chiyuki Yamato
,
Kensaku Kinoshita
Analytical Biochemistry
1979
Corpus ID: 42601227
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE